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Abstract
Background: Previously, we reported that the ‘‘antioxidant’’ compound ‘‘mitoQ’’ (mitochondrial-targeted ubiquinol/
ubiquinone) actually increased superoxide production by bovine aortic endothelial (BAE) cell mitochondria incubated with
complex I but not complex II substrates.
Methods and Results: To further define the site of action of the targeted coenzyme Q compound, we extended these studies to
include different substrate and inhibitor conditions. In addition, we assessed the effects of mitoquinone on mitochondrial
respiration, measured respiration and mitochondrial membrane potential in intact cells, and tested the intriguing hypothesis
that mitoquinone might impart fuel selectivity in intact BAE cells. In mitochondria respiring on differing concentrations of
complex I substrates, mitoquinone and rotenone had interactive effects on ROS consistent with redox cycling at multiple sites
within complex I. Mitoquinone increased respiration in isolated mitochondria respiring on complex I but not complex II
substrates. Mitoquinone also increased oxygen consumption by intact BAE cells. Moreover, when added to intact cells at 50 to
1000 nM, mitoquinone increased glucose oxidation and reduced fat oxidation, at doses that did not alter membrane potential
or induce cell toxicity. Although high dose mitoquinone reduced mitochondrial membrane potential, the positively charged
mitochondrial-targeted cation, decyltriphenylphosphonium (mitoquinone without the coenzyme Q moiety), decreased
membrane potential more than mitoquinone, but did not alter fuel selectivity. Therefore, non-specific effects of the positive
charge were not responsible and the quinone moiety is required for altered nutrient selectivity.
Conclusions: In summary, the interactive effects of mitoquinone and rotenone are consistent with redox cycling at more
than one site within complex I. In addition, mitoquinone has substrate dependent effects on mitochondrial respiration,
increases repiration by intact cells, and alters fuel selectivity favoring glucose over fatty acid oxidation at the intact cell level.
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Introduction
Mitochondria are likely the predominant source of reactive
oxygen species (ROS) in many cell types [1–4]. This is
underscored by recent evidence that mitochondrial oxidative
damage may underlie problems including cell damage in
degenerative diseases and aging [5–7], vascular disease, and
complications of diabetes [8–16]. Given the vascular nature of
these problems understanding the role of mitochondrial oxidative
stress in endothelial cells is particularly important.
Concern over the contribution of ROS to vascular and
degenerative disease, has led to attempts at antioxidant therapy.
Efforts are now underway to develop effective antioxidant
compounds targeted to mitochondria [17,18]. In particular, targeted
forms of coenzyme Q have attracted attention and are under
development as therapeutic agents [19]. However, the effects of
targeted CoQ on ROS production by mitochondria are still not well
understood. Moreover, little is known of the metabolic consequences
of loading mitochondria with Coenzyme Q (CoQ10) analogs.
In past studies of bovine aortic endothelial (BAE) cell
mitochondria, we demonstrated that a mitochondrial targeted
CoQ compound termed ‘‘mitoQ’’ (mitoquinone, mitoquinol, or a
mixture of these two redox cycling compounds) markedly
increased or decreased reactive oxygen species (ROS) generation
depending on substrate provided for fuel [20]. MitoQ markedly
increased superoxide production during forward electron trans-
port in mitochondria respiring on the complex I (NADH:ubiqui-
none oxidoreductase) substrates, glutamate plus malate. On the
other hand mitoQ inhibited ROS generated by BAE mitochon-
dria respiring on the complex II (succinate:ubiquinone oxidore-
ductase) substrate, succinate, a condition wherein ROS production
occurs through reverse electron transport or backflow of electrons
to complex I originating from complex II.
During respiration on complex I substrates, superoxide appears
to result from redox cycling of endogenous CoQ10 or exogenous
analogs at Q-binding sites within complex I [20–22]. Recently a
two site model for mitoquinone redox cycling in complex I was
proposed with one site proximal and one distal to the site of
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rotenone inhibition at the N2 iron-sulfur cluster [21]. Our previous
work showed that the effect of mitoquinone on ROS production was
rotenone sensitive [20]. Therefore, in this work we examined ROS
production as affected by different relative concentrations of
mitoquinone and rotenone to determine whether simple dose
dependent effects or more complex interactions were involved,
which might be better explained by a two-site model.
Further, and perhaps of greater importance, we addressed the
issues of whether mitoquinone might induce a substrate specific
increase in mitochondrial oxygen consumption (as might be
expected given the substrate specific effects on ROS) and whether
this might be associated with alterations in cellular respiration and
nutrient selectivity. This could follow based on the following
reasoning. Complex I substrates generate NADH which donates
electrons to complex I. In contrast, electron donation at other
entry sites including complex II and the ETF-ubiquinone
reductase requires FADH2. Glucose oxidation through glycolysis
and pyruvate dehydrogenase to acetyl CoA generates NADH. In
contrast, fatty acid oxidation to acetyl-CoA generates FADH2
through the process of b-oxidation. Acetyl CoA from both sources
feeds the TCA cycle. So, although mitochondrial fatty acid b-
oxidation is more efficient in terms of total reducing equivalents
generated per molecule, glucose oxidation compared to fat
oxidation generates proportionally more NADH (as a percent of
total reducing equivalents generated). So, we reasoned that if
mitoquinone were more effective at generating oxygen radicals on
substrates that produce NADH (complex I substrates) than those
which generate FADH2, then mitoquinone might also increase
respiration on complex I substrates more than complex II
substrates. If so, mitoquinone might favor metabolism of nutrients
that generate proportionately more NADH than FADH2 which
might then translate to proportionately more (in the presence of
mitoquinone versus absence) use of glucose than fat.
The issue of fuel selectivity is of high interest in the fields of
diabetes, obesity, and associated cardiovascular disease. In fact
lack of metabolic ‘‘flexibility’’ such as the capacity to switch
between fat and glucose oxidation has been implicated in cardiac
complications of diabetes [23,24] and in the pathogenesis of
insulin resistance as seen in type 2 diabetes and obesity [25].
Here we report novel information covering two important
issues. First we provide new data on the interactions of
mitoquinone and rotenone at different concentrations of complex
I substrates and discuss the implications for redox cycling at
complex I. Second, we provide novel data demonstrating that
mitoquinone does in fact alter respiration and fuel selectivity by
intact cells. Finally we consider the effects of mitoquinone on
mitochondrial membrane potential and whether such effects might
affect fuel selectivity and/or cell toxicity.
Materials and Methods
Reagents and supplies
Mitoquinone and mitoquinol were synthesized from commercially
available 11-bromoundecanoic acid and 2,3-dimethoxy-5-methyl-
1,4-benzoquinone as described [26,27]. Other reagents, kits, and
supplies were as specified or purchased from standard sources.
MitoQ consists of the quinone/quinol moiety of endogenous
coenzyme Q, linked to a 10 carbon side chain, covalently bound to
triphenylphosphonium. Control compounds included endogenous
coenzyme Q, decylTPP consisting of triphenylphosphonium and the
10 carbon chain of mitoQ but without the quinone moiety, and
decylQ consisting of the carbon chain and quinone/quinol moiety
but without the targeting cation. The molecular structures of these
compounds are included in supplementary material (Methods S1).
Primary antibodies included mouse monoclonal anti-porin
(A21317, Invitrogen, Carlsbad, CA), goat polyclonals anti-actin
and anti-histone deacetylase-1 (HDAC1)(sc-1615 and sc-6298,
respectively, Santa Cruz Biotechnologies, Santa Cruz, CA), and
rabbit anti-catalase IgG (01-05-030000, Athens Research and
Technology, Athens, GA). Secondary antibodies consisted of goat
anti-mouse, donkey anti-goat, and goat anti-rabbit (Santa Cruz).
Cell culture. BAE cells were grown in medium M199
(Invitrogen) supplemented with minimal essential medium amino
acids (Invitrogen), penicillin/streptomycin (Invitrogen), minimal
essential medium vitamins (Sigma), and 20% fetal bovine serum
(HyClone, Logan, UT) as described [28]. Cells were grown to near
confluence in 150-cm2 flasks and used between passages 6 and 12.
Isolation of Mitochondria
Cells were washed with phosphate buffered saline (PBS) and
scraped. Collected cells were homogenized using a Dounce
homogenizer in ice-cold homogenization buffer (0.25 M sucrose,
5 mM HEPES, 0.1 mM EDTA, pH 7.2) with 0.1% fatty acid-free
bovine serum albumin (BSA). The homogenate was centrifuged at
10006g for 10 min. The pellet was discarded and the supernatant
was centrifuged again at 10,0006g for 10 min to obtain the
mitochondrial pellet. The resulting pellet was then washed three
times in homogenization buffer without BSA and resuspended in
media as described below. Protein was determined by the
Bradford method (BioRad, Hercules, CA). Mitochondria prepared
in this way were of good quality as documented by an increase in
respiratory rate of 3.5–6 fold after addition of carbonyl cyanide p-
[trifluoromethoxy]-phenyl-hydrazone (FCCP) as an uncoupler.
Purity of mitochondria prepared in this way was documented by
assessing mitochondrial and intact cell expression of the
mitochondrial protein, porin; the cytoplasmic protein, catalase;
the nuclear protein, HDAC1; and actin by immunoblot analysis.
In our mitochondrial studies, all individual experiments (each n of
1) compare conditions within the same preparation, so the extent
of purity would be the same for all conditions.
Immunoblotting
Ten mg protein per lane were loaded and separated by 12.5%
polyacrylamide gel electrophoresis and electroblotted to nitrocellu-
lose membranes (Millipore Corp., Bedford, MA). For porin, blots
were incubated with mouse anti-porin, 1:25,000, in TTBS (tris
buffered saline, pH 7.6 with 1 ml/L TWEEN 20)/2.5% BSA
overnight at 4uC. For actin, blots were blocked with TTBS/5% milk
at RT for 1 h and incubated in goat anti-actin, 1:2000, in TTBS/
2.5% BSA overnight at 4uC. For HDAC1, blots were incubated in
goat anti-HDAC1, 1:500, in TTBS/2.5% BSA overnight at 4uC. For
catalase, blots were incubated in rabbit anti-catalase, 1:2500 in
TTBS/2.5% BSA overnight at 4uC. Following primary antibody
incubations, blots were washed in TTBS, and incubated in secondary
Ab, 1:20,000, for 1 hour at room temperature in TTBS/5% milk.
After secondary antibody incubations, blots were washed with TTBS
and developed by enhanced chemiluminescence using a standard kit
(ECL, Amersham Pharmacia Biotech, Piscataway, NJ).
Mitochondrial respiration
Mitochondrial respiration was measured as we previously
described [20,29] using a Clark miniature oxygen electrode and
small (0.6 ml) volume chamber with stir bar (Instech Laboratories,
Inc., Plymouth Meeting, PA) at 37uC in ionic respiratory buffer
(120 mM KCl, 5 mM KH2PO4, 2 mM MgCl2, 1 mM EGTA,
3 mM HEPES, pH 7.2 with 0.3% fatty acid free BSA). Isolated
mitochondria (0.5 mg protein/ml) were incubated in the respira-
tory media and oxygen consumption quantified. To determine
MitoQ, ROS, and Metabolism
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state 4 and state 3 respiration, oxygen consumption was
continuously recorded with sequential additions of 5 mM
succinate, 0.2 mM ADP, and finally 2.5 mM carbonyl cyanide p-
[trifluoromethoxy]-phenyl-hydrazone (FCCP) to induce maximal
chemical uncoupling using standard methodology as we have
employed in the past [30]. The ADP:O ratio was determined in
standard fashion as we have carried out in the past [30], calculated
as ADP added divided by oxygen consumed during the duration of
state 3 respiration
Mitochondrial ROS production
Mitochondria were studied during state 4 respiration, under
which circumstance oxygen radical formation is enhanced as
electron flow leads to high potential unmitigated by ATP generation
[31]. H2O2 production was assessed as we previously described [20]
using the fluorescent probe 10-acetyl-3,7-dihydroxyphenoxazine
(DHPA) (Amplex Red, Invitrogen, Carlsbad, CA). In the presence of
horseradish peroxidase, DHPA reacts with H2O2 to generate the
fluorescent compound resorufin. ROS detected in this way derives
largely from superoxide converted to H2O2 by matrix superoxide
dismutase and released externally. As we previously showed by
inhibitor analysis and by comparison to complex III superoxide
detected by electron paramagnetic resonance spectroscopy (EPR)
[20], and as shown by others [32], H2O2 detected in this way largely
derives from superoxide released by complex I.
Samples were prepared in 96-well plates containing 0.06 ml per
well of respiratory buffer. Fluorescence was measured as we
previously described [20] once every 60 seconds and carried out
for 30 cycles. For quantification, a H2O2 standard curve ranging
from 0–12 mM was prepared and included on each plate. Addition
of substrates, mitoquinone, or diphenyleneiodinium chloride (DPI)
to respiratory buffer did not affect the H2O2 standard curve.
Addition of rotenone at 5 mM (maximum dose used) slightly raised
the height of the standard curve at all points with no change in
slope so the data were corrected for this factor. The lower doses of
rotenone utilized in this work had no effect on the standard curve.
Addition of catalase, 500 units/ml, reduced fluorescence to
below the detectable limit indicating specificity for H2O2. Addition
of the ETS inhibitors rotenone or DPI or tested quinone or control
compounds to mitochondria in the absence of substrate altered
fluorescence no more than 5%.
Respiration by intact BAE cells
We used a method adapted from perfusion methodology
designed to quantify oxygen use by cells under microscopy [33].
Here we grew BAE cells on glass microcarrier beads (Cytodex,
Sigma Life Sciences, Inc.) enabling perfusion on a column in bead
volumes of 1.0–1.5 ml at flow rates of 1–1.5 ml/min. Respiration
was quantified as the steady state difference in oxygen tension
determined between electrodes placed proximal and distal to the
column. The electrodes could be precisely calibrated to each other
by shunting medium around the perfusion column through a
control bead column without cells. Oxygen use per volume of
beads perfused is given by the difference in oxygen tension and
known flow rate[(% drop in O2 content across the column6oxy-
gen content at atmospheric pressure (nmol/ml)6flow rate (ml/
min)]/bead volume (ml). The apparatus and a sample run are
depicted in supplementary material (Methods S1).
Oxygen consumption depends on bead volume, flow rate, and
the number of cells per bead volume. Bead volume and flow rates
were identical for each of three experiments comparing mitoqui-
none to control (decylQ). Although we did not quantify the
number of cells per bead volume the same preparations were used
for mitoquinone and control in each experiment so any variation
with cell number would be identical for mitoquinone and control.
An example run is shown in supplemental material (Methods S1)
wherein FCCP was added at the end demonstrating the expected
transient increase in O2 consumption with chemical uncoupling.
Glucose and Oleate oxidation
Cells were washed and then preincubated for 20 min in culture
medium with 5.5 mM glucose, and either 10 mM or 200 mM
oleate with 1.5% fatty acid-free BSA, and 1 mM carnitine in 12-
well plates (Costar, Corning Inc., Acton, MA) containing 0.6 ml
total volume per well. MitoQ (1 mM) or control compounds at the
same concentration were added at the beginning of the 20 min
preincubation (time 220 min) before addition of label at time 0.
Separate groups of experiments were performed in the presence of
oleate, 200 mM, and oleate, 10 mM. In each group of experiments
glucose and oleate oxidation were assessed in parallel studies under
the same conditions except for the addition of either [1–14C]oleic
acid or D-[14C(U)]glucose. Cells were incubated for 120 min
before trapping of CO2 released by perchloric acid as we
previously described [30]. Final specific activities in the incubation
media were 1.526106 mCi/pmol for cold oleate at 200 mM (total
oleate with label 206 mM) and 20.1 mCi/pmol for cold oleate at
10 mM (total oleate with label 15.7 mM). Final specific activity of
glucose was 0.04636103 mCi/nmol for cold glucose at 5.5 mM
(total glucose with label 5.6 mM).
An additional group of experiments were carried out to
determine the dose-response characteristics of the mitoquinone
on fuel selectivity. These experiments were preformed in the same
fashion except that cells were exposed to various concentrations of
mitoquinone or vehicle in culture medium overnight (18 h) before
addition of [1–14C]oleic acid or D-[14C(U)]glucose and 50 mM
cold oleate at time zero (before the 120 minute incubation with
label). Final specific activity of oleate was 5.616106 mCi/pmol
(total oleate with label 56 mM). Final specific activity of glucose
was 0.04636103 mCi/nmol (total glucose with label 5.6 mM).
Mitochondrial membrane potential
Cells were exposed to various doses of mitoquinone, decylTPP,
CoQ10, or vehicle in culture medium overnight for 18 h. The
potential sensitive probe, JC-1 was then added at a concentration
of 0.5 mg/ml for one hour and washed with Earle’s balanced salt
solution before determining red and green fluorescence at
excitation and emission wavelengths 544/590 and 485/520
respectively. The red to green ratio was calculated as an index
of mitochondrial potential.
Cell toxicity assays
Toxicity was assayed by two methods. First, the ability of cells to
convert the redox dye resazurin into resorufin, a property lost by
cells as metabolic activity is impaired [34], was determined using a
kit (CellTiter-Blue, Promega). BAE cells were treated overnight
with mitoquinone or control compounds prior to end point
addition of the resazurin reagent for three h. Conversion of
resorufin was determined by fluorescence at excitation of 560 nm
and emission at 590. Second we assayed cell membrane integrity
by measuring LDH released into the culture medium in
comparison to a standard curve. To prepare the curve, BAE cells
were fully lysed and pooled to generate an LDH concentration
reflective of 100% lysis and serial dilutions made generating a
curve representing LDH (fluorescence) versus estimated percent
lysis. Background fluorescence (about 9% of total) was subtracted
in each assay. The assay was carried out using a kit (CytoTox-
ONE, Promega) according to the manufacturer’s recommended
protocol.
MitoQ, ROS, and Metabolism
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Statistics
Data were analyzed by ANOVA with post-tests as indicated.
Results
Purity of BAE cell mitochondria
BAE mitochondria were highly pure as shown by the relative
expression of the mitochondrial specific protein, porin; the
cytoplasmic protein, catalase; the nuclear protein, HDAC1; and
actin in mitochondrial and whole cell fractions (figure 1). It is
possible that there is very minor contamination of mitochondria
with nuclear particles based on a faint HDAC1 signal in the
mitochondrial fraction.
Substrate dependent effects of mitoQ on mitochondrial
ROS production
Consistent with our previous findings [20], mitoQ markedly
increased H2O2 production in the presence of the complex I
substrates, glutamate and malate, while reducing H2O2 produc-
tion in the presence of the complex II fuel, succinate. Here we
show similar findings (figure 2) when mitochondria were incubated
in the presence of pyruvate which can also donate electrons to
complex I through NADH. Tested compounds demonstrated
minimal non-specific fluorescence as evidenced by the data
generated in the absence of substrate.
Substrate dependent effects of mitoQ on mitochondrial
respiration
Figure 3 shows the effect of mitoquinone, compared to CoQ10
or vehicle, on respiration in isolated BAE mitochondria deter-
mined by polarography using a Clarke electrode to measure O2
utilization. These data show that mitoquinone significantly
increased state 4 respiration by isolated BAE mitochondria
respiring on the complex I substrates, glutamate and malate.
Mitoquinone resulted in a non-significant decrease in respiration
on the complex II fuel, succinate. Essentially, the same results were
observed when respiration was expressed as a percentage of
maximal respiration determined in the presence of the chemical
uncoupler FCCP. Mitoquinone resulted in similar, but non-
significant, alterations in state 3 respiration. Mitoquinone did not
significantly alter the ADP:O ratio in mitochondria respiring on
complex I or Complex II substrates.
ROS production in the presence of complex I inhibitors
In pilot experiments, we noted that rotenone inhibits the effect
of mitoquinone on ROS in the presence of complex I substrates.
However the effect seemed to change as different doses of these
compounds were tested. Figure 4 depicts the effect of mitoquinone
at different concentrations of rotenone on H2O2 production by
BAE mitochondria fueled with complex I substrates. As shown, the
effect of increasing the rotenone dose is biphasic, first increasing
then decreasing mitoquinone induced ROS, thus generating the
inverse U-shaped relationship. By two-way ANOVA, the data are
highly interactive (p,0.001) indicating that the effect of
mitoquinone is highly dependent on the rotenone concentration.
In other experiments, we examined the effect of 5 mM DPI,
which inhibits the FMN site of complex I, on ROS production as
affected by mitoquinone at different rotenone concentrations. As
shown, DPI reduced the effect of mitoquinone at all doses of
rotenone. Since, there is evidence that DPI may also act on
mitochondrial chloride channels [35], we tested the effect of the
compound using a chloride free buffer system substituting
gluconate for chloride in the respiratory medium. Although the
effects of mitoquinone and rotenone appeared to be mildly altered
in this non-physiologic buffer, DPI again appeared to block the
effect of mitoquinone at all doses of rotenone (figure 5).
Effect of mitoQ on respiration in intact BAE cells
Given the effects of mitoquinone on respiration in isolated
mitochondria we extended these studies to whole cell respiration.
This was done by perfusing cells grown on glass beads and
measuring the difference in oxygen tension as recorded by electrodes
placed proximal and distal to the perfused cells in a manner in which
the two electrodes could be precisely calibrated to each other (see
supplementary material, Methods S1). The effect of additions to the
perfusion medium could then be determined by the change from
steady state oxygen consumption prior to and after exposure to the
test condition. Addition of mitoquinone resulted in an incremental
oxygen consumption rate (beyond that of buffer perfused cells) of
6562 (mean6SE) nmol O/min/ml bead volume whereas there was
essentially no incremental change when the control compound,
decylQ was added (figure 6). In each individual experiment
comparing mitoquinone to control, the same bead volume and
bead preparation were used for both compounds. The mean basal
oxygen consumption before addition of these compounds was
5666 nmol/min/ml bead volume (n = 6) and did not differ between
compounds. In additional experiments, which employed separate
bead preparations, oxygen consumption after addition of 2.0 mM
FCCP was 229645 nmol/min/ml bead volume (n = 5). A fourth
determination of incremental oxygen consumption in the presence of
mitoquinone, but with no control, revealed a value of 46 nmol/min/
ml bead volume.
Effect of mitoquinone on fuel selectivity in the intact BAE
cell
Figure 7 demonstrates the effect of mitoquinone compared to
vehicle and control compounds on glucose and oleate oxidation by
intact BAE cells determined as CO2 production from labeled glucose
or oleate. For a given experiment, fat and glucose oxidation were
determined in cells grown side by side seeded in individual wells at
the same time. Two groups of experiments were performed; first
comparing glucose and oleate oxidation in cells at 5.5 mM glucose
and 200 mM oleate (before added label) and a second group in cells
at 5.5 mM glucose and 10 mM oleate (before added label). Each
individual data point actually represents the mean of triplicate
determinations in cells grown in separate wells. The absolute values
for glucose and oleate oxidation in the presence of vehicle were
4.9660.85 nmol/well and 216647 pmol/well in panels A and B,
respectively, and 6.4560.63 nmol/well and 11.864.3 pmol/well in
panels C and D, respectively.
Figure 1. Mitochondria were highly purified as demonstrated
by the relative expression of the mitochondrial specific
protein, porin; the cytoplasmic protein, catalase; the nuclear
protein, HDAC1; and actin in mitochondrial (M) and whole cell
(W) fractions. Extracts were subject to immunoblot analysis using the
antibody to the indicated protein. Findings are representative of four
different mitochondrial preparations.
doi:10.1371/journal.pone.0004250.g001
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As indicated, mitoquinone enhanced glucose oxidation
(figures 7A and 7C) and inhibited oleate oxidation (figures 7B
and 7D), although the effect on oleate oxidation was significant
only at the higher oleate concentration. At the higher oleate
concentrations, mitoquinone increased glucose oxidation by
222635% of vehicle compared to little change for the control
compounds (CoQ10, decylQ, or decylTPP). Mitoquinone de-
creased oleate oxidation by 5064% of vehicle, again compared to
essentially no change for the controls. The complex I inhibitor,
rotenone, reduced oxidation of both oleate and glucose.
We also determined the dose-response characteristics for the
effect of mitoquinone on fuel selectivity. These studies were carried
out as above except that the oleate concentration was 50 mM and
the exposure time to mitoquinone or vehicle was overnight or
18 h. We found a significant dose response relationship extending
well down into the nM range (figure 8). The absolute values for
glucose and oleate oxidation in the presence of vehicle were
6.2160.54 nmol/well and 71618 pmol/well respectively.
Mitochondrial membrane potential
Cells were exposed overnight to 100 nM to 1.0 mM concentra-
tions of mitoquinone, CoQ10, or decylTPP or to vehicle (ethanol)
under the same conditions used to study fat and glucose oxidation
(figure 9). As shown in figure 9A, mitoquinone and, to a greater
extent, decylTPP reduced membrane potential. For mitoquinone,
the effect was significant only at the highest dose.
Cell toxicity
These assays were done in order to test the possibility that
mitoquinone or control compounds could induce cytotoxicity,
which would raise concern regarding possible non-specific effects
on mitochondrial or intact cell fuel utilization or on fuel selectivity.
Cells were exposed overnight to 100 nM to 1.0 mM concentrations
of mitoquinone, CoQ10, or decylTPP or to vehicle (ethanol),
again under the same conditions used to study fat and glucose
oxidation (figure 8). We observed no difference in reduction of
resazurin to resorufin by BAE cells exposed to any mitoquinone
concentration compared to vehicle (figure 9B). Toxicity was
observed only at the highest concentration of decylTPP.
Conceivably, mitoquinone or control compounds could alter dye
reduction. Therefore, we also assessed LDH release from cells
treated in this fashion. For all treatments, LDH release was less
than 1% of that observed from cells lysed after culture under the
same conditions over three separate assays (data not shown).
Discussion
Our past work [20] showed that mitoQ had prooxidant or
antioxidant effects on mitochondria respiring on complex I or
complex II substrates, respectively. In this work we expand these
studies to add additional information concerning the localization
of these effects within the electron transport pathways of complex
I. Perhaps, of greater importance, we found that mitoquinone
Figure 2. Effect of mitoquinone (mQN) and mitoquinol (mQL) compared to control compounds on H2O2 production by isolated BAE
mitochondria fueled by different substrates. Mitochondria were incubated in respiratory buffer under state 4 conditions fueled by pyruvate
(pyr), glutamate (glut)+malate (mal), or succinate (succ) as indicated above the individual graphs. Added compounds (1.0 mM), vehicle, or FCCP
(2.5 mM) were present as indicated on the X-axis. Data represent mean6SE, * p,0.01 compared to vehicle by ANOVA. n = 6 mitochondrial
preparations for all data points. Each individual value represents the mean of two replicate wells.
doi:10.1371/journal.pone.0004250.g002
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increased mitochondrial respiration selectively on complex I
substrates leading to our finding that mitoquinone altered nutrient
selectivity at the intact cell level.
Figure 2 confirms our previous findings of the prooxidant effect
of mitoquinone during respiration on the complex I substrates
glutamate and maleate and provides new information showing
that mitoquinone has similar effects on superoxide production in
mitochondria fueled by the complex I substrate, pyruvate. This is
consistent with the concept that mitoQ to enhances superoxide
production at the level of complex I per se and is not specific for any
particular NADH generating reaction. As shown in figure 2,
decylTPP which lacks the quinone moiety does not increase ROS,
nor do CoQ or decylQ which lack the cation moiety and do not
easily penetrate mitochondria [17,18].
The major reason for the prooxidant effect of mitoQ is probably
redox cycling within complex I. This was suggested by Doughan
Figure 3. Effect of mitoquinone (mQN) compared to CoQ10 and vehicle on respiration by isolated BAE mitochondria fueled by
different substrates. Mitochondria were incubated under state 4 and state 3 conditions fueled by 5 mM glutamate plus 1 mM malate (panels A, B,
C) or 5 mM succinate (panels D, E, F). Mitochondria were exposed to 1.0 mM CoQ10, 1.0 mM mitoquinone (mQN), or vehicle (Veh) as indicated.
Respiration is expressed in absolute terms (panels A,C,D,E) or as percent of maximal respiration induced by 2.5 mM FCCP (panels B and E). The ADP:O
ratio is depicted in panels G and H. Data represent mean6SE, * p,0.05 compared to CoQ10 or vehicle (panel A) or to CoQ10 (panel B), ? p,0.01
compared to vehicle (panel B) by ANOVA, n = 13 for all incubations.
doi:10.1371/journal.pone.0004250.g003
MitoQ, ROS, and Metabolism
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and Dikalov [21] who recently used inhibitor analysis to propose a
model wherein mitoQ undergoes highly efficient redox cycling at
two sites within complex I, one proximal and one distal to the
putative rotenone binding site, where rotenone is believed to block
electron transfer from the N2 iron-sulfur cluster to ubiquinone
Figure 4. Interactive effect of rotenone and mitoquinone on
H2O2 production by BAE mitochondria fueled by 5 mM
glutamate plus 1 mM malate incubated in respiratory buffer
under state 4 conditions. Mitochondria were exposed to mitoqui-
none (mQN) and/or rotenone at the concentrations indicated. Data
represent mean6SE, n = 4 for each data point. * p,0.001 or non-
significant (ns) compared to 0 mM mQN by 2-way ANOVA (factors are
mQN and rotenone). There was significant interaction (p,0.001)
between factors indicating the effect of mQN is dependent on the
rotenone concentration.
doi:10.1371/journal.pone.0004250.g004
Figure 5. Effect of diphenyleneiodinium chloride (DPI) on H2O2 production by BAE mitochondria as affected by mitoquinone
(mQN) at different doses of rotenone (Rot). Mitochondria were fueled by 5 mM glutamate plus 1 mM malate and incubated as in figure 4. Panel
A) Mitochondria were incubated in respiratory buffer with no additions. Panel B) Addition of 5 mM DPI. Panel C) Mitochondria were incubated in
chloride free respiratory buffer (gluconate substituted for chloride) with no additions. Panel D) Addition of 5 mM DPI in chloride free buffer. Data
represent mean6SE, n = 10 in panels A and B, n = 6 in panels C and D. * p,0.05, { p,0.01, ? p,0.001 for mitoquinone compared to absence of the
compound. Data were analyzed by 2-way ANOVA (factors mQN or Rot). Interaction was significant in panels A, B, and D.
doi:10.1371/journal.pone.0004250.g005
Figure 6. Oxygen consumption by cells perfused on glass
beads exposed to mitoquinone (1 mM) or the control com-
pound decylQ (1 mM). Values (mean6SE) represent incremental
changes in oxygen consumption (compared to perfusate alone) after
addition of mitoquinone or decylQ to the perfusion medium. * p,0.001
compared to control (n = 3).
doi:10.1371/journal.pone.0004250.g006
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[21,36]. Our data (figure 4) are compatible with this two-site
model since redox cycling at a single site does not easily account
for the inverted U-shaped relationship between ROS production
and rotenone in the presence of mitoquinone (figure 4).
As shown in our current (figure 2) and past work [20], both
mitoquinone and mitoquinol increase ROS production on
complex I substrates consistent with redox cycling properties.
Although in all experiments these compounds markedly increase
ROS on complex I substrates, we must acknowledge substantial
variation in the magnitude of ROS production from experiment to
experiment, for example, compare figure 2 to figures 4 and 5. We
also observed such variation in past studies [20]. We can only
speculate regarding the reason for this. We suggest that BAE
mitochondria are highly sensitive to these quinone compounds,
but that the exact magnitude of ROS generated may be sensitive
to subtle differences in conditions from experiment to experiment
or in groups of experiments carried out at different times. Perhaps
this involves subtle differences in temperature or buffer conditions,
in the time it takes to isolate and incubate mitochondria, or the
exact nature of mitochondrial preparations from cells grown at
different times. In any case, we point out that in all experiments,
we compare these quinone/quinol compounds to control
conditions within the same mitochondrial preparations, so that
the relative effects of these compounds can not be explained by
any such variation.
DPI acts proximal to the rotenone site in complex I blocking
electron transfer at the FMN site. So the inhibition of the
mitoquinone effect at all doses of rotenone by DPI (figure 5) is
compatible with mitoquinone action at and/or distal to the FMN
site. Existing models of mammalian complex I (which is still an
unresolved issue) suggest that FMN (after accepting electrons from
NADH), transfers electrons to a chain of iron-sulfur clusters
eventually to an N2 site that interacts with ubiquinone [37,38].
Therefore, if the two site model for mitoquinone cycling is correct
(one proximal and one distal to rotenone action at N2) as proposed
[39], the DPI data (figure 5) suggest the proximal mitoquinone site
is localized at FMN or in the iron-sulfur chain proximal to N2.
In contrast to its prooxidant effect in the presence of complex I
substrates, mitoquinone decreased ROS production by mitochon-
dria respiring on succinate (figure 2). Under these conditions
considerable electron transport is directed retrograde through
complex I, by reverse electron transport, a phenomenon known to
Figure 7. Effect of mitoquinone or control compounds on glucose and oleate oxidation. BAE cells were preincubated for 20 min in the
presence of culture medium with 5.5 mM glucose plus 200 mM oleate (panels A and B) or 5.5 mM glucose plus 10 mM oleate (panels C and D). D-
[14C(U)]glucose (panels A and C) or [1-14C]oleic acid (panels B and D) were added at time 0 and cells incubated for 120 min before trapping CO2. Final
glucose and oleate concentrations after addition of label were 5.6 mM glucose+200 mM oleate (panel A), 5.5 mM glucose+206 mM oleate (panel B),
5.6 mM glucose+10 mM oleate (panel C) and 5.5 mm glucose+15.7 mM oleate (panel D). 1.0 mM mitoquinone or control compounds or 5 mM
rotenone (Rot) were added at time 220 min and continued during subsequent incubation. Data are expressed relative to incubation in the presence
of vehicle alone, a condition included for study of each cell preparation. Numbers in parentheses designate number of preparations. Data represent
mean6SE, * p,0.05 or ** ,0.01 compared to non-targeted CoQ10 by one-way ANOVA.
doi:10.1371/journal.pone.0004250.g007
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be sensitive to membrane potential [20,22,40,41]. In fact, our
results show that mitoQ does, in fact, reduce membrane potential
(figure 9), so this may explain the effect of mitoQ to reduce ROS
generated by mitochondria respiring on succinate. However, as
opposed to ROS production generated by reverse electron
transport on succinate, reduced membrane potential does not
appear to underlie the effect of mitoQ to increase ROS during
forward electron transport (respiration on complex I substrates).
This is because the compound, decylTPP (mitoquinone minus the
quinone/quinol moiety) reduced potential even more than
mitoquinone (figure 9) but had no effect to increase ROS during
forward electron transport (figure 2).
Our current findings using JC-1 to assess potential as affected by
mitoQ in intact cells differs from our past results which utilized the
distribution of radiolabeled tetraphenylphosphonium inside and
outside isolated mitochondria to assess potential [20]. Using that
methodology, we did not see a difference in membrane potential in
mitochondria exposed to mitoQ compared to controls. Although
we suspected that even a slight reduction in potential might be
responsible for the effect of mitoQ to decrease ROS during reverse
transport, we concluded that we could not detect it. However, our
current data now support this concept.
The substrate-specific effects we observed on ROS production
from isolated mitochondria, led us to question whether mitoQ
might have similar substrate specific affects on mitochondrial
respiration and whether that might translate to intact cell
respiration and fuel selectivity at the intact cell level. In fact,
mitoquinone did increase mitochondrial oxygen consumption in
the presence of complex I but not complex II substrates (figure 3).
Of note is that the overall incremental increase in respiration on
glutamate plus malate induced by mitoquinone under state 4
conditions was approximately 4 nmoles/mg/min (figure 3). In
comparison, the mitoquinone-induced increase in ROS produc-
tion measured as H2O2 generated per mg per min was in the
picomolar range (figures 2,4,5). Thus, increased radical formation
per se does not account for the overall increase in mitochondrial
respiration suggesting a further effect of mitoquinone. A possible
reason for this may be a compensatory increase in respiration as a
result of the decrease in membrane potential [42].
As shown in figure 6, mitoquinone increased repiration by intact
BAE cells as well as isolated mitochondria. However, of greater
interest was the effect of mitoquinone to impart fuel selectivity at
the intact cell level, enhancing glucose oxidation while reducing
the oxidation of the monounsaturated fatty acid oleate. We had
hypothesized that this would be the case based on our observations
regarding the substrate specific effect of mitoquinone on
mitochondrial ROS production and respiration (see introduction).
The importance of fuel selectivity is underscored by studies
indicating that ‘‘metabolic inflexibility’’ or impaired capacity to
switch between nutrient utilization, in particular between fatty
acid and glucose oxidation, has a pathogenic role in the insulin
resistance commonly seen in type 2 diabetes and obesity [25].
Metabolic inflexibility may also be important in cardiac adaptation
to stress [23,24].
According to the classic Randle hypothesis fat and glucose
metabolism compete and undergo regulation based on the acetyl-
CoA/CoA ratio and citrate concentrations with consequent effects
on enzymes regulating glucose and fat metabolism. Later work did
not verify this, but placed emphasis on intracellular signaling
pathways [43]. More recent metabolomic studies now suggest that
enhanced fat metabolism, as seen with high fat feeding, leads to b-
oxidation products that exceed mitochondrial capacity restricting the
ability to switch to glucose oxidation [25]. That work [25] places
emphasis on impaired mitochondrial function suggesting an induced
mitochondrial defect but it is unclear what this actually is or exactly
how the defect comes into play. Although, our work does not resolve
this issue, it does lead to the important conclusion that a primary
perturbation at the mitochondrial level (exposure to mitoquinone)
can indeed have substantial effects to alter fuel selectivity.
Of course, there are many possible reasons why mitoquinone
might alter nutrient selectivity. This will require extensive additional
study. Speculative possibilities include mitochondrial redox effects
which could affect the state of cytoplasmic reducing equivalents with
consequent effects on a myriad of enzyme systems and kinases.
These could then alter fuel selectivity at notable steps such as AMPK
kinase, pyruvate dehydrogenase, phosphofructokinase, or others.
Moreover, it is possible that mitoquinone might have direct effects on
mitochondrial proteins such as the pyruvate dehydrogenase complex
or the electron transport flavoprotein (ETF):ubiquinone oxidore-
ductase. The later possibility is intriguing since inhibition might
impair electron donation by FADH2. This might reduce fat
oxidation since mitochondrial b-oxidation generates FADH2 which
Figure 8. Dose-dependent effect of mitoquinone compared to
vehicle on glucose and oleate oxidation. BAE cells were incubated
overnight (16 h) in the presence of culture medium with 5.5 mM
glucose. [1-14C]oleic acid (panel A) or D-[14C(U)]glucose (panel B) along
with 50 mM oleate were added at time 0 and cells incubated for
120 min before trapping CO2. Final glucose and oleate concentrations
after addition of label were 5.6 mM glucose+50 mM oleate (panel A) or
5.5 mM glucose+56 mM oleate (panel B). Data are expressed relative to
incubation in the presence of vehicle alone. Data represent mean6SE
(n = 4 for each determination). * p,0.05 or ** ,0.01 compared to
vehicle by one-way ANOVA with repeated measures.
doi:10.1371/journal.pone.0004250.g008
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is oxidized by theETF:ubiquinone oxidoreductase donating elec-
trons to the ETS independent of complex I or complex II. Moreover,
from the lack of effect of decylTPP+ compared to mitoquinone
(figure 7), it appears that the quinone moiety of mitoquinone is
essential for its effect on nutrient selectivity.
For several reasons our work suggests that the effects of
mitoquinone on ROS production, and respiration occur at complex
I. These include the effect of mitoquinone to increase ROS and
respiration selectively on complex I substrates (figures 2 and 3), the
effect of mitoquinone to decrease superoxide during reverse electron
transport to complex I, the interactions of mitoquinone with
rotenone and DPI (figure 5), and the knowledge that ROS as
detected by DHPA represents matrix superoxide released from
complex I (see methods). Our data are not definitive with respect to
whether mitoquinone action on complex I is directly related to its
effect on intact cell nutrient selectivity. However, given the
considerations discussed above regarding the use of mitochondrial
reducing equivalents, together with the effects of mitoquinone on
mitochondrial respiration, our results at least suggest that complex I
effects are involved. Although speculative, our work, also raises the
possibility that complex I and endogenous CoQ10 might have
similar interactions to affect cell nutrient selectivity. In this regard,
there is evidence that the effects of complex I substrates to generate
mitochondrial ROS may involve endogenous Q binding sites within
complex I [22]. Of course, this issue will require more study and
might be aided by better resolution of the structure and function of
mammalian complex I in general.
We examined fuel selectivity initially at high and low oleate
concentrations, 200 mM and 10 mM, respectively, and subsequently
at an intermediate concentration of 50 mM for our dose-response
studies. These concentrations were arbitrarily chosen. For perspec-
tive, physiologic nonesterified (free) fatty acid concentrations in
humans can range widely up to nearly 1 mM depending on nutrient
and hormonal status and even higher is some disease states [43]. Of
course, oleate represents only a single fatty acids so it is difficult to
determine the optimal concentration for study. Oleate in circulating
human serum, present among the complex mix of fatty acids, can
range roughly 10 to 400 mM [44,45].
We considered the possibility that the effects of mitoQ on glucose
use by intact cells (figures 7 and 8) could reflect a non-specific
response to cell toxicity. However, this does not appear to be the case
for several reasons. First, we found no evidence for this in our
cytotoxic assays. Second, our dose response studies demonstrated
effects of mitoquinone extending an order of magnitude or more
downward from the 1 mM (or higher) dose used in other reported
studies of the cellular actions of this compound [46–48] some of
which reported a mitoQ induced resistance to apoptosis [46,47].
Third, although reduced potential might be construed as suggesting
cell toxicity, decylTPP (which is also positively charged and differs
from mitoQ only in the absence of the Q moiety) did not affect fuel
selectivity (figure 7A and 7B) despite greater reduction in membrane
potential than mitoquinone (figure 9A). Thus, the effects of
mitoquinone are dependent on the quinone moiety and are not
explained by membrane potential alone. Finally, we point out that
rotenone, which is well known to decrease respiration by complex I
inhibition, did not increase glucose oxidation in BAE cells but had
the opposite effect (figure 7A and 7B).
Our current work has implications towards the development of
mitoQ or related compounds as possible therapeutic agents useful
as antioxidants. Possibly this approach might have benefit beyond
Figure 9. Dose-dependent effects of mitoquinone (mQN), CoQ10, and decylTPP on mitochondrial membrane potential in intact
BAE cells and upon cell toxicity. Panel A) Membrane potential estimated as the ratio of red to green fluorescence of the potential sensitive probe,
JC-1. Panel B) Cell toxicity estimated as fluorescence generated by reduction of resazurin to resorufin. For both panels, values represent mean6SE,
n = 3 for each data point, * p,0.01 compared to the zero concentration by repeated measures ANOVA.
doi:10.1371/journal.pone.0004250.g009
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antioxidant properties and extend to improved ability to use
glucose countering the above mentioned effects of diabetes and
insulin resistance. It is also important to recognize that although
we observed prooxidant rather than antioxidant effects of
mitoquinone with complex I substrates, the semiquinone gener-
ated by redox cycling of either endogenous CoQ10 or mitoQ may
have the beneficial effect of acting as a chain breaking antioxidant
[49]. Given the well known vascular nature of the complications of
diabetes and the role of atherosclerosis in heart disease and stroke,
vascular endothelial cells may be particularly important as targets
for antioxidant protection. Moreover, the regulation of endothelial
cell glucose use is also an important issue since enhanced glucose
consumption is recognized as an adaptive metabolic response to
ischemia or hypoxia.
In summary, we provide new data demonstrating that: 1) The
prooxidant effects of mitoQ extend to respiration on pyruvate. 2)
The prooxidant effects are perturbed by rotenone, but in a
complex fashion consistent with action at more than one Q
binding site. 3) Importantly, mitoquinone increases mitochondrial
respiration in substrate-specific fashion, increases intact BAE cell
respiration, and imparts fuel selectivity in the intact cell favoring
glucose while inhibiting fat oxidation. 4) MitoQ decreases
membrane potential, which likely explains its effect to reduce
ROS during reverse electron transport. However, the prooxidant
effects of mitoQ and the effects on fuel selectivity are not explained
by decreased membrane potential and require the quinone moiety
of the compound.
Supporting Information
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